Cure Ingredients Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 281.78%
(FY 2021)
- Profit 66.62%
(FY 2021)
- Ebitda 82.39%
(FY 2021)
- Net Worth -17.25%
(FY 2021)
- Total Assets 69.73%
(FY 2021)
About Cure Ingredients
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Chintagunta and Srinivas Chintagunta serve as directors at the Company.
- CIN/LLPIN
U74999TG2017PTC118222
- Company No.
118222
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cure Ingredients Private Limited offer?
Cure Ingredients Private Limited offers a wide range of products and services, including Ayur, Boswellia Capsule, Pure Herbs, Boswellia Serrata, Dengue Platelet Capsule, Fresh Vegetables, Dehydrated Spinach Flakes, Processed Food Items, Quinoa Flakes, Nutritional Supplements.
Who are the key members and board of directors at Cure Ingredients?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Chintagunta  | Director | 09-Jul-2018 | Current |
| Srinivas Chintagunta | Director | 13-Feb-2023 | Current |
Financial Performance of Cure Ingredients.
Cure Ingredients Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 281.78% increase. The company also saw a substantial improvement in profitability, with a 66.62% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure Ingredients?
In 2021, Cure Ingredients had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Teckbond Laboratories Private LimitedActive 20 years 11 monthsSanjeev Chintagunta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cure Ingredients?
Unlock and access historical data on people associated with Cure Ingredients, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
